|
|
|
Insider
Information: |
Tyree James L |
Relationship: |
Director |
City: |
Abbott Park |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
286,780 |
|
Indirect Shares
|
1,199 |
|
|
Direct
Value |
$14,809,066 |
|
|
Indirect Value
|
$123,341 |
|
|
Total
Shares |
287,979 |
|
|
Total
Value |
$14,932,407 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-80.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Abbott Laboratories |
ABT |
Executive Vice President |
2009-02-27 |
132,176 |
2009-02-27 |
1,199 |
Premium* |
|
Innoviva Inc |
INVA |
Director |
2017-04-20 |
70,554 |
2014-06-02 |
0 |
Premium* |
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-10-20 |
0 |
2015-05-22 |
0 |
Premium* |
|
Assertio Holdings Inc |
ASRT |
Director |
2019-05-08 |
80,590 |
2019-05-07 |
0 |
Premium* |
|
Genelux Corp |
GNLX |
Director |
2023-12-13 |
3,460 |
2023-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ABT |
Abbott Laboratories |
Senior Vice President |
|
2006-08-15 |
4 |
D |
$47.96 |
$542,332 |
D/D |
(11,308) |
92,365 |
|
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-05-14 |
4 |
D |
$54.40 |
$637,840 |
D/D |
(11,725) |
119,241 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2016-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,795 |
26,119 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
12,000 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2006-02-14 |
4 |
OE |
$33.23 |
$419,879 |
D/D |
12,635 |
79,238 |
|
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2015-05-22 |
4 |
AS |
$7.45 |
$94,593 |
D/D |
(12,703) |
14,324 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-02-25 |
4 |
OE |
$42.50 |
$542,612 |
D/D |
12,768 |
156,289 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,912 |
33,487 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-07-09 |
4 |
D |
$57.37 |
$755,620 |
D/D |
(13,171) |
121,344 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2006-08-15 |
4 |
OE |
$33.23 |
$510,338 |
D/D |
13,267 |
103,673 |
|
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-05-14 |
4 |
OE |
$41.95 |
$575,277 |
D/D |
13,489 |
130,966 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
13,950 |
35,620 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2005-05-01 |
4 |
A |
$48.66 |
$686,106 |
D/D |
14,100 |
66,603 |
|
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-03-03 |
4 |
S |
$53.19 |
$778,892 |
D/D |
(14,638) |
128,112 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2014-06-02 |
4/A |
A |
$0.00 |
$0 |
D/D |
15,170 |
15,170 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-07-09 |
4 |
OE |
$45.45 |
$694,185 |
D/D |
15,274 |
134,515 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2016-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
18,328 |
53,948 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2017-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
19,857 |
70,554 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2017-05-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,362 |
53,849 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2007-08-22 |
4 |
D |
$52.36 |
$1,077,778 |
D/D |
(20,584) |
105,959 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2007-02-20 |
4 |
D |
$52.49 |
$1,175,146 |
D/D |
(22,388) |
120,470 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2007-08-22 |
4 |
OE |
$40.93 |
$983,029 |
D/D |
23,891 |
126,543 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2007-02-20 |
4 |
OE |
$41.03 |
$1,058,536 |
D/D |
25,798 |
142,858 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2006-02-17 |
4 |
A |
$44.16 |
$1,170,240 |
D/D |
26,500 |
95,041 |
|
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2015-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,027 |
27,027 |
0 |
- |
|
89 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|